Mitsubishi UFJ Asset Management Co. Ltd. Invests $34.73 Million in The Cooper Companies, Inc. $COO

Mitsubishi UFJ Asset Management Co. Ltd. bought a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 484,342 shares of the medical device company’s stock, valued at approximately $34,732,000.

Several other institutional investors also recently bought and sold shares of the stock. OneDigital Investment Advisors LLC purchased a new position in Cooper Companies during the second quarter valued at approximately $410,000. Simplicity Wealth LLC purchased a new stake in Cooper Companies in the 2nd quarter worth approximately $224,000. J.Safra Asset Management Corp purchased a new stake in Cooper Companies in the 2nd quarter worth approximately $32,000. Global Retirement Partners LLC acquired a new stake in shares of Cooper Companies during the 2nd quarter worth approximately $117,000. Finally, Bank of New York Mellon Corp acquired a new stake in shares of Cooper Companies during the 2nd quarter worth approximately $73,642,000. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

Cooper Companies Price Performance

Cooper Companies stock opened at $76.73 on Thursday. The company’s fifty day moving average price is $71.59 and its 200 day moving average price is $71.16. The Cooper Companies, Inc. has a 1 year low of $58.89 and a 1 year high of $89.83. The stock has a market capitalization of $14.96 billion, a P/E ratio of 65.03, a P/E/G ratio of 1.98 and a beta of 0.83. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.78 and a current ratio of 1.27.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, topping the consensus estimate of $1.10 by $0.11. The company had revenue of $1.08 billion during the quarter, compared to analyst estimates of $1.05 billion. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The firm’s revenue was up 7.9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. As a group, equities research analysts anticipate that The Cooper Companies, Inc. will post 4.63 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on COO shares. KeyCorp reiterated a “sector weight” rating on shares of Cooper Companies in a research note on Friday, June 5th. Needham & Company LLC dropped their price target on shares of Cooper Companies from $101.00 to $86.00 and set a “buy” rating on the stock in a research report on Friday, June 5th. JPMorgan Chase & Co. cut their price objective on shares of Cooper Companies from $80.00 to $71.00 and set a “neutral” rating for the company in a report on Friday, June 5th. Citigroup reissued a “neutral” rating and set a $80.00 target price (up from $76.00) on shares of Cooper Companies in a research note on Thursday, August 13th. Finally, The Goldman Sachs Group set a $61.00 price target on Cooper Companies in a research note on Wednesday, May 27th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $81.64.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.